The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.00
Bid: 165.00
Ask: 175.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.061%)
Open: 170.00
High: 170.00
Low: 170.00
Prev. Close: 170.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Dec 2017 15:35

RNS Number : 4158Z
Helios Underwriting Plc
14 December 2017
 

Helios Underwriting plc ("Helios" or the "Company")

Director/PDMR Shareholding

Ordinary Shares issued under the Company's Joint Share Ownership Plan ("JSOP")

Helios announces that, on 14th December 2017, it issued and allotted 500,000 new ordinary shares of £0.10 each ("Ordinary Shares"). The new Ordinary Shares have been issued at a subscription price of 133.5p per Ordinary Share, being the closing price of an Ordinary Share on 13th December 2017, pursuant to The Helios Underwriting plc Employees' Joint Share Ownership Plan (the "Plan").

The new Ordinary Shares have been issued into the respective joint beneficial ownership of (i) each of the participating executive Directors listed below and (ii) the trustee of the Trust upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director, the Company and the Trustee. The nominal value of the new Ordinary Shares has been paid by the Trust out of funds advanced to it by the Company with the additional consideration of 123.5p left outstanding until such time as new Ordinary Shares are sold. The Company has waived its lien on the Shares such that there are no restrictions on their transfer.

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the jointly owned Ordinary Shares above the greater of either:

a) the initial market value (133.5p per share), less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value accruing over the three years from the date of award) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost; or

 

b) if higher, 150p (so that the participating Director will only ever receive value if the share sale price exceeds this).

The vesting of the award will be subject to performance conditions measured over the three calendar years from the award date.

Note:

The Plan was established and approved by resolution of the Remuneration Committee of the Company on 13 December 2017 and provides for the acquisition by employees, including executive directors, of beneficial interests as joint owners (with the Trust) of Ordinary Shares in the Company upon the terms of a JOA. The terms of the JOA provide that if the jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners on the terms set out above.

Effect of the transactions

The beneficial interests of the executives following the transaction will be as follows:

Director

Interests in jointly owned Ordinary Shares issued under JSOP

Other interests in Ordinary Shares

Total Shareholding

Arthur Manners

200,000

133,334

333,334

Nigel Hanbury

300,000

2,436,871

2,736,871

 

Application for Admission of Ordinary Shares and total Voting Rights

Application has been made for the admission to trading on AIM ("Admission") of the 500,000 new Ordinary Shares, and it is expected that Admission will be effective on 20 December 2017.

The new Ordinary Shares will rank pari passu with the Company's existing issued Ordinary Shares. The Company's issued share capital following Admission will comprise 15,104,240 Ordinary Shares with voting rights and no restrictions on transfer and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

For further information please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive 020 7863 6655 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

 

Stockdale Securities Limited

Robert Finlay 020 7601 6100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEZLFFDLFXFBX
Date   Source Headline
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202112:57 pmEQSHardman & Co Research : Hardman & Co Video Event | Helios Underwriting Plc - Investor Forum
27th Apr 20217:00 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSDirectorate Changes
20th Apr 202111:35 amRNSHolding(s) in Company
1st Apr 202112:34 pmRNSResult of GM, TVR and Directors' Participation
1st Apr 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
30th Mar 20217:00 amRNSResult of Open Offer
11th Mar 20217:00 amRNSDirector/PCA Shareholding
9th Mar 20217:00 amRNSResult of Placing and Subscription
8th Mar 20214:45 pmRNSFundraising to raise up to approximately £60m
16th Feb 20211:37 pmRNSRevision to Adjusted Net Asset Value
8th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.